We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Improved Medication Adherence and Frequency of Blood Glucose Self-Testing Using an m-Health Platform Versus Usual Care in a Multisite Randomized Clinical Trial Among People with Type 2 Diabetes in India.
- Authors
Kleinman, Nora J.; Shah, Avani; Shah, Sanjiv; Phatak, Sanjeev; Viswanathan, Vijay
- Abstract
Background: In 2015, India had an estimated 69.2 million people with diabetes and a national prevalence of 8.7%. Evidence is mounting for the benefits of telemedicine in diabetes care, but remains limited on mobile-health (m-Health) interventions. Introduction: This study assessed the impact of an m-Health diabetes platform on clinical outcomes, patientreported outcomes, patient and provider satisfaction, and app usage. Materials and Methods: This open-label, two-arm parallel study enrolled 91 people at 3 sites in India, aged 18-65, with type 2 diabetes, and an A1c between 7.5% and 12.5% (58-113 mmol/mol). Participants were randomly assigned 1:1 to m-Health or usual care and observed for 6 months. All received free visits, laboratory tests, transportation fees, and strips and lancets. Intervention participants received the m-Health app and a mobile phone data stipend. Results: A1c change was previously reported as statistically significant. Significantly more participants in intervention than control had improved medication adherence (39.0% vs. 12.8%; p = 0.03) and increased frequency of blood glucose (BG) self-testing (39.0% vs. 10.3%; p = 0.01) at 6 months from baseline. No other outcomes were significantly different. Among m-Health users, 75% of participants actively used the app at week 24. Participants entered 29,668 medications and 2,575 BG readings, sent 497 messages, and received 890 messages. Most participants (80%) were satisfied with all aspects of the app and all seven providers rated the software very acceptable. Discussion: Participants assigned to m-Health had increased medication adherence and frequency of BG testing compared with usual care participants. Conclusions: This tool could be an effective way to expand access to quality chronic disease care and improve outcomes.
- Subjects
PEOPLE with diabetes; BLOOD sugar monitoring; CLINICAL trials; MOBILE health; DIGITAL technology; HEALTH information exchanges; TELEMEDICINE; GLUCOSE
- Publication
Telemedicine & e-Health, 2017, Vol 23, Issue 9, p733
- ISSN
1530-5627
- Publication type
Article
- DOI
10.1089/tmj.2016.0265